INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $85,705 | -56.0% | 25,060 | -32.4% | 0.00% | 0.0% |
| Q1 2016 | $195,000 | -33.0% | 37,083 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $291,000 | -3.6% | 37,083 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $302,000 | -23.9% | 35,720 | -1.4% | 0.00% | -33.3% |
| Q2 2015 | $397,000 | -26.8% | 36,229 | -6.5% | 0.00% | -25.0% |
| Q1 2015 | $542,000 | -17.1% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $654,000 | +25.8% | 38,742 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $520,000 | +5.3% | 38,742 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $494,000 | +7.2% | 38,742 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $461,000 | -13.8% | 38,742 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $535,000 | -20.9% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $676,000 | +7.3% | 38,742 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $630,000 | – | 38,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |